| Title |
Erythropoiesis‐stimulating agents for anemia in rheumatoid arthritis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2013
|
| DOI | 10.1002/14651858.cd000332.pub3 |
| Pubmed ID | |
| Authors |
Arturo J Martí-Carvajal, Luis H Agreda-Pérez, Ivan Solà, Daniel Simancas-Racines |
| Abstract |
Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disorder that mainly affects the small joints of the hands and feet. Erythropoiesis-stimulating agents have been used to treat anemia, one of the extra-articular manifestations of RA. Although anemia is less of a problem now because of the reduction in inflammation due to disease-modifying antirheumatic drugs (DMARDs), it could still be an issue in countries where DMARDs are not yet accessible. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 2 | 50% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 197 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 1% |
| United States | 1 | <1% |
| Sri Lanka | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 192 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 26 | 13% |
| Researcher | 22 | 11% |
| Student > Bachelor | 18 | 9% |
| Student > Ph. D. Student | 17 | 9% |
| Student > Postgraduate | 10 | 5% |
| Other | 41 | 21% |
| Unknown | 63 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 76 | 39% |
| Nursing and Health Professions | 19 | 10% |
| Psychology | 9 | 5% |
| Biochemistry, Genetics and Molecular Biology | 5 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Other | 17 | 9% |
| Unknown | 66 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 July 2023.
All research outputs
#1,627,422
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#3,507
of 13,156 outputs
Outputs of similar age
#12,294
of 205,561 outputs
Outputs of similar age from Cochrane database of systematic reviews
#45
of 211 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 205,561 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 211 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.